Daniel David Eshtiaghpour

Daniel Eshtiaghpour practices at Specialty Surgical Center of Encino in Encino, California.

Daniel Eshtiaghpour's NPI, 1962780148, was assigned on July 22, 2011. Daniel Eshtiaghpour graduated from Jefferson Medical College of Thomas Jefferson University in 2011. Daniel Eshtiaghpour holds California license A122301.

Daniel Eshtiaghpour's primary practice is Specialty Surgical Center of Encino, at 16501 Ventura Blvd, Suite 103, Encino, CA 91436. The practice phone is (818) 501-1080.

Daniel Eshtiaghpour's primary practice is Specialty Surgical Center of Encino in Encino, California. Daniel Eshtiaghpour is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UCLA Medical Group. Dmand AI also links Daniel Eshtiaghpour to 2 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Daniel Eshtiaghpour practices, 5 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Daniel Eshtiaghpour's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Daniel Eshtiaghpour is licensed in California.

CMS data shows 943 Medicare services from Daniel Eshtiaghpour across 8 procedure codes in 2024, for 416 Medicare patients. Medicare paid $92,533 for them.

CMS counts 416 Medicare patients who saw Daniel Eshtiaghpour in 2024. The largest group is 65 to 74, with 209 patients. 75% of them have high cholesterol, and 71% have high blood pressure. 30% are also on Medicaid. Their average risk score is 1.66, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Daniel Eshtiaghpour's median patient age at 54, with 53% women.

In 2024, Daniel Eshtiaghpour wrote 2,124 Medicare Part D claims for 518 patients. 83% of them were for generic drugs. CMS names the drug for 1,886 of them, across 29 drugs with 11 or more claims each, at $358,723 in total drug cost. In 2023, CMS named 1,533 claims across 28 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Daniel Eshtiaghpour for performance year 2024, reported as part of a group. Daniel Eshtiaghpour accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Daniel Eshtiaghpour as offering telehealth. CMS counts 63 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Daniel Eshtiaghpour, more than 67% of the clinicians it reports for that procedure.

Dmand AI links 3 papers to Daniel Eshtiaghpour, published from 2011 to 2016. Daniel Eshtiaghpour's most frequent co-authors are Viktor E. Eysselein, MD, David Sokoyoon Chung, MD and Sofiya Reicher, MD.

CMS Open Payments shows 235 general payments to Daniel Eshtiaghpour from 16 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 97% of the total. Abbvie Inc. paid the most, $2,418.

Daniel Eshtiaghpour graduated from Jefferson Medical College of Thomas Jefferson University in 2011.